Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radmila Santic

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Plos One|January 23, 2015
Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccinesMarkus Mandler, Radmila Santic, Petra Gruber, et al.
Neuropeptides|June 10, 2005
Galanin and galanin receptors in human cancersAlexandra Berger, Radmila Santic, Cornelia Hauser-Kronberger, et al.
Experimental Eye Research|November 27, 2012
Distribution of the regulatory peptide alarin in the eye of various speciesFalk Schrödl, Andrea Trost, Clemens Strohmaier, et al.
The Journal of Investigative Dermatology|April 23, 2004
Expression of neuropeptide galanin and galanin receptors in human skinBarbara Kofler, Alexander Berger, Radmila Santic, et al.
Journal of Molecular Neuroscience : MN|September 7, 2006
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide geneRadmila Santic, Katrin Fenninger, Kerstin Graf, et al.
Molecular Neurodegeneration|April 18, 2015
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophyMarkus Mandler, Elvira Valera, Edward Rockenstein, et al.
Acta Neuropathologica|February 15, 2014
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trialsMarkus Mandler, Elvira Valera, Edward Rockenstein, et al.
Acta Neuropathologica|May 28, 2014
Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's diseaseMarkus Mandler, Lauren Walker, Radmila Santic, et al.
Scientific Reports|August 30, 2018
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancerSarah Hochmann, Michaela Mittermeir, Radmila Santic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2019
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like modelMarkus Mandler, Edward Rockenstein, Cassia Overk, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|January 23, 2015
Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccinesMarkus Mandler, Radmila Santic, Petra Gruber, et al.
Neuropeptides|June 10, 2005
Galanin and galanin receptors in human cancersAlexandra Berger, Radmila Santic, Cornelia Hauser-Kronberger, et al.
Experimental Eye Research|November 27, 2012
Distribution of the regulatory peptide alarin in the eye of various speciesFalk Schrödl, Andrea Trost, Clemens Strohmaier, et al.
The Journal of Investigative Dermatology|April 23, 2004
Expression of neuropeptide galanin and galanin receptors in human skinBarbara Kofler, Alexander Berger, Radmila Santic, et al.
Journal of Molecular Neuroscience : MN|September 7, 2006
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide geneRadmila Santic, Katrin Fenninger, Kerstin Graf, et al.
Molecular Neurodegeneration|April 18, 2015
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophyMarkus Mandler, Elvira Valera, Edward Rockenstein, et al.
Acta Neuropathologica|February 15, 2014
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trialsMarkus Mandler, Elvira Valera, Edward Rockenstein, et al.
Acta Neuropathologica|May 28, 2014
Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's diseaseMarkus Mandler, Lauren Walker, Radmila Santic, et al.
Scientific Reports|August 30, 2018
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancerSarah Hochmann, Michaela Mittermeir, Radmila Santic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2019
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like modelMarkus Mandler, Edward Rockenstein, Cassia Overk, et al.
Pageof 2